Sustainability Features

Designed with sustainability in mind because sustainability is an emerging priority

Carbon Trust Certification1,2,3

FLEXBUMIN® 25% is the first medical product certified by the Carbon Trust

Lower carbon footprint

Using just 4 containers of FLEXBUMIN 25% (100 mL) per day for a week instead of glass bottles provides the same CO2 reduction as using 3 fewer gallons of gasoline4*

Reduced waste volume

It takes more than 8 discarded FLEXBUMIN 25% containers to equal the weight of just 1 discarded glass bottle of equal volume5*

Safe end-of-life disposal

Internal container film is composed of PVDC; meaning the container film can be processed without creating harmful residues such as dioxins when incinerated according to established industry standards.6,7

**Calculations based on bottles of BUMINATE 25% [Albumin (Human)] USP, 25% Solution
Polyvinylidene chloride (PVDC)

 1. The Carbon Trust Certification Limited. Carbon Footprint Certification Letter CTFCC/PAS/2012/CE/5998. London, England: Carbon Trust; September 26, 2012. 2. Data on File. FLEXBUMIN Life Cycle Assessment, 2009. Baxter Healthcare Corporation. 3. www.baxter.com/press_room/press_releases/2010/06_24_10_sustainability.html. Accessed 7/23/14 4. Final Results for Albumin Packaged as FLEXBUMIN and Buminate, 2012. Deloitte Consulting. 5. Data on File. Market Analysis: Regulated Medical Waste Disposal Cost Assessment, 2010. Baxter Healthcare Corporation. 6. Saran PVDC Resins & Films and the Environment, 2005. DOW Form No. 190-00500-0305. 7. Data on File. Biologics License Application. Baxter Healthcare Corporation.